<VariationArchive VariationID="646736" VariationName="NM_000137.4(FAH):c.548_553+20del" VariationType="Deletion" Accession="VCV000646736" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2019-08-14" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="653068" VariationID="646736">
      <GeneList>
        <Gene Symbol="FAH" FullName="fumarylacetoacetate hydrolase" GeneID="2184" HGNC_ID="HGNC:3579" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="80152789" stop="80186949" display_start="80152789" display_stop="80186949" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="80445232" stop="80478923" display_start="80445232" display_stop="80478923" Strand="+" />
          </Location>
          <OMIM>613871</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000137.4(FAH):c.548_553+20del</Name>
      <CanonicalSPDI>NC_000015.10:80168143:ATGACTGTGAGTGACCGCAGCGTCCA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="80168144" stop="80168169" display_start="80168144" display_stop="80168169" variantLength="26" positionVCF="80168143" referenceAlleleVCF="GATGACTGTGAGTGACCGCAGCGTCCA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="80460486" stop="80460511" display_start="80460486" display_stop="80460511" variantLength="26" positionVCF="80460485" referenceAlleleVCF="GATGACTGTGAGTGACCGCAGCGTCCA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.80168144_80168169del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.80168144_80168169del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.80460486_80460511del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.80460486_80460511del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012833.1" sequenceAccession="NG_012833" sequenceVersion="1" change="g.20146_20171del">
            <Expression>NG_012833.1:g.20146_20171del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374377.1" sequenceAccession="NM_001374377" sequenceVersion="1" change="c.548_553+20del">
            <Expression>NM_001374377.1:c.548_553+20del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374380.1" sequenceAccession="NM_001374380" sequenceVersion="1" change="c.548_553+20del">
            <Expression>NM_001374380.1:c.548_553+20del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000137.4" sequenceAccession="NM_000137" sequenceVersion="4" change="c.548_553+20del" MANESelect="true">
            <Expression>NM_000137.4:c.548_553+20del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="768180953" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000137.4(FAH):c.548_553+20del AND Tyrosinemia type I" Accession="RCV000801084" Version="6">
        <ClassifiedConditionList TraitSetID="6267">
          <ClassifiedCondition DB="MedGen" ID="C0268490">Tyrosinemia type I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-16" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-16" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-08-14" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12203990</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31568711</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9101289</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9633815</ID>
        </Citation>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6267" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15974" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tyrosinemia type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tyrosinemia type I</ElementValue>
                <XRef ID="Tyrosinemia+type+1/7281" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010161" DB="MONDO" />
                <XRef ID="410056006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatorenal tyrosinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fumarylacetoacetase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FAH deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deficiency of fumarylacetoacetase</ElementValue>
                <XRef ID="124536006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TYRSN1</ElementValue>
                <XRef Type="MIM" ID="276700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Untreated tyrosinemia type I usually presents either in young infants with severe liver involvement or later in the first year with liver dysfunction and renal tubular dysfunction associated with growth failure and rickets. Untreated children may have repeated, often unrecognized, neurologic crises lasting one to seven days that can include change in mental status, abdominal pain, peripheral neuropathy, and/or respiratory failure requiring mechanical ventilation. Death in the untreated child usually occurs before age ten years, typically from liver failure, neurologic crisis, or hepatocellular carcinoma. Combined treatment with nitisinone and a low-tyrosine diet has resulted in a greater than 90% survival rate, normal growth, improved liver function, prevention of cirrhosis, correction of renal tubular acidosis, and improvement in secondary rickets.</Attribute>
                <XRef ID="NBK1515" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2658" />
                <XRef ID="2658" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000568295" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000264964" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301688</ID>
                <ID Source="BookShelf">NBK1515</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Tyrosine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased Tyrosine, Tyrosinemia, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Tryosine-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Tyrosine Elevated, Succinylacetone Normal, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Tyrosine-Normal-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Tyrosine Normal/Elevated, Succinylacetone Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="882" DB="Orphanet" />
              <XRef ID="C0268490" DB="MedGen" />
              <XRef ID="MONDO:0010161" DB="MONDO" />
              <XRef Type="MIM" ID="276700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1834772" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="5284659|MedGen:C0268490" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000940842" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9101289</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9633815</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12203990</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31568711</ID>
          </Citation>
          <Comment>This variant results in the deletion of part of exon 6 (c.548_553+20del) of the FAH gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FAH are known to be pathogenic (PMID: 9101289, 9633815). This variant is present in population databases (rs768180953, gnomAD 0.01%). This variant has been observed in individual(s) with tyrosinemia type I (PMID: 12203990, 31568711). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as E6/I6del26. ClinVar contains an entry for this variant (Variation ID: 646736). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FAH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.80460486_80460511del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268490" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7847698" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000137.4:c.548_553+20del|OMIM:276700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004195868" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000137.4:c.548_553+20del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="276700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7847698" TraitType="Disease" MappingType="XRef" MappingValue="276700" MappingRef="OMIM">
        <MedGen CUI="C0268490" Name="Tyrosinemia type I" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1834772" TraitType="Disease" MappingType="XRef" MappingValue="C0268490" MappingRef="MedGen">
        <MedGen CUI="C0268490" Name="Tyrosinemia type I" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

